Patents Assigned to New England Medical Center, Inc.
  • Polypeptide-toxin hybrid protein
    Patent number: 4468382
    Abstract: A hybrid protein toxic to cells having linear neuropeptide receptors such as TRH receptors comprising a linear neuropeptide such as TRH covalently bonded to CRM 45 is useful for treatment of tumors.
    Type: Grant
    Filed: July 15, 1982
    Date of Patent: August 28, 1984
    Assignee: New England Medical Center, Inc.
    Inventors: Patricia Bacha, Seymour Reichlin, John R. Murphy
  • Intravenously administrable iron supplement
    Patent number: 4315942
    Abstract: The iron (III) complexes of the formulaFe(RCONHOH).sub.3wherein R is H or lower alkyl, are excellent iron supplements which are even intravenously administrable.
    Type: Grant
    Filed: May 21, 1979
    Date of Patent: February 16, 1982
    Assignee: New England Medical Center, Inc.
    Inventor: Brian J. Corden